Vincerx Pharma Inc.

12/07/2021 | Press release | Distributed by Public on 12/07/2021 07:11

Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma